Rockwell Medical Inc
RMTI0.849USD
-0.001-0.09%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
33.46MMarket Cap
LossP/E TTM
More Details of Rockwell Medical Inc Company
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Rockwell Medical Inc Info
Ticker SymbolRMTI
Company nameRockwell Medical Inc
IPO dateJan 27, 1998
CEOStrobeck (Mark)
Number of employees244
Security typeOrdinary Share
Fiscal year-endJan 27
Address30142 Wixom Road
CityWIXOM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code48393
Phone18004493353
Websitehttps://www.rockwellmed.com/
Ticker SymbolRMTI
IPO dateJan 27, 1998
CEOStrobeck (Mark)
Company Executives of Rockwell Medical Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
Other
84.57%
Shareholders
Shareholders
Proportion
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
Other
84.57%
Shareholder Types
Shareholders
Proportion
Corporation
9.03%
Investment Advisor
4.95%
Individual Investor
4.20%
Hedge Fund
2.01%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.09%
Venture Capital
0.04%
Other
78.21%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
Radie (Robert Samuel)
143.52K
0.42%
+50.00K
+53.46%
May 20, 2025
Timmins (Megan Carden)
142.68K
0.41%
+97.50K
+215.79%
May 20, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
Dimensional US Core Equity 1 ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
Date
Type
Ratio
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
FAQs
Who are the top five shareholders of Rockwell Medical Inc?
The top five shareholders of Rockwell Medical Inc are:
Irrevocable Larson Family Investment Trust holds 3.56M shares, accounting for 10.33% of the total shares.
The Vanguard Group, Inc. holds 1.21M shares, accounting for 3.50% of the total shares.
Renaissance Technologies LLC holds 541.75K shares, accounting for 1.57% of the total shares.
Geode Capital Management, L.L.C. holds 320.67K shares, accounting for 0.93% of the total shares.
Strobeck (Mark) holds 290.62K shares, accounting for 0.84% of the total shares.
Irrevocable Larson Family Investment Trust holds 3.56M shares, accounting for 10.33% of the total shares.
The Vanguard Group, Inc. holds 1.21M shares, accounting for 3.50% of the total shares.
Renaissance Technologies LLC holds 541.75K shares, accounting for 1.57% of the total shares.
Geode Capital Management, L.L.C. holds 320.67K shares, accounting for 0.93% of the total shares.
Strobeck (Mark) holds 290.62K shares, accounting for 0.84% of the total shares.
What are the top three shareholder types of Rockwell Medical Inc?
The top three shareholder types of Rockwell Medical Inc are:
Irrevocable Larson Family Investment Trust
The Vanguard Group, Inc.
Renaissance Technologies LLC
Irrevocable Larson Family Investment Trust
The Vanguard Group, Inc.
Renaissance Technologies LLC
How many institutions hold shares of Rockwell Medical Inc (RMTI)?
As of 2025Q3, 98 institutions hold shares of Rockwell Medical Inc, with a combined market value of approximately 6.21M, accounting for 18.04% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -17.52%.
What is the biggest source of revenue for Rockwell Medical Inc?
In FY2025Q2, the Concentrate Products business generated the highest revenue for Rockwell Medical Inc, amounting to 16.07M and accounting for --% of total revenue.
